KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Short term Debt (2016 - 2025)

Labcorp Holdings' Short term Debt history spans 17 years, with the latest figure at $500.1 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 50.0% year-over-year to $500.1 million; the TTM value through Dec 2025 reached $500.1 million, down 50.0%, while the annual FY2025 figure was $500.1 million, 50.0% down from the prior year.
  • Short term Debt for Q4 2025 was $500.1 million at Labcorp Holdings, down from $1.0 billion in the prior quarter.
  • Across five years, Short term Debt topped out at $1.0 billion in Q4 2024 and bottomed at $1.5 million in Q4 2021.
  • The 5-year median for Short term Debt is $500.1 million (2025), against an average of $560.6 million.
  • The largest annual shift saw Short term Debt tumbled 99.6% in 2021 before it surged 19986.67% in 2022.
  • A 5-year view of Short term Debt shows it stood at $1.5 million in 2021, then soared by 19986.67% to $301.3 million in 2022, then surged by 231.83% to $999.8 million in 2023, then grew by 0.05% to $1.0 billion in 2024, then tumbled by 50.0% to $500.1 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Short term Debt are $500.1 million (Q4 2025), $1.0 billion (Q4 2024), and $999.8 million (Q4 2023).